Analysis | Samples | Factors | Units |
---|---|---|---|
ESI negative ion mode | S00015978 | Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015979 | Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016046 | Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015980 | Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015981 | Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016047 | Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016048 | Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015974 | Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015975 | Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016043 | Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016044 | Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015976 | Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015977 | Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016045 | Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016013 | Recovery:na | Gender:female | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016014 | Recovery:na | Gender:female | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016015 | Recovery:na | Gender:female | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016081 | Recovery:na | Gender:female | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016082 | Recovery:na | Gender:female | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016083 | Recovery:na | Gender:female | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016016 | Recovery:na | Gender:male | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016017 | Recovery:na | Gender:male | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016018 | Recovery:na | Gender:male | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016084 | Recovery:na | Gender:male | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016085 | Recovery:na | Gender:male | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00016086 | Recovery:na | Gender:male | Treatment:No antibiotics | ug/100mg sample weight |
ESI negative ion mode | S00015952 | Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015953 | Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016019 | Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016020 | Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016021 | Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015986 | Recovery:no recovery | Gender:female | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015987 | Recovery:no recovery | Gender:female | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016052 | Recovery:no recovery | Gender:female | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016053 | Recovery:no recovery | Gender:female | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016054 | Recovery:no recovery | Gender:female | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016010 | Recovery:no recovery | Gender:female | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016011 | Recovery:no recovery | Gender:female | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016012 | Recovery:no recovery | Gender:female | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016078 | Recovery:no recovery | Gender:female | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016079 | Recovery:no recovery | Gender:female | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016080 | Recovery:no recovery | Gender:female | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016006 | Recovery:no recovery | Gender:female | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016007 | Recovery:no recovery | Gender:female | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016073 | Recovery:no recovery | Gender:female | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016074 | Recovery:no recovery | Gender:female | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016075 | Recovery:no recovery | Gender:female | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016000 | Recovery:no recovery | Gender:female | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016001 | Recovery:no recovery | Gender:female | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016002 | Recovery:no recovery | Gender:female | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016067 | Recovery:no recovery | Gender:female | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016068 | Recovery:no recovery | Gender:female | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016069 | Recovery:no recovery | Gender:female | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00015954 | Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015955 | Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016022 | Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016023 | Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016024 | Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015988 | Recovery:no recovery | Gender:male | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015989 | Recovery:no recovery | Gender:male | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015990 | Recovery:no recovery | Gender:male | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016055 | Recovery:no recovery | Gender:male | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016056 | Recovery:no recovery | Gender:male | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016057 | Recovery:no recovery | Gender:male | Treatment:IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016008 | Recovery:no recovery | Gender:male | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016009 | Recovery:no recovery | Gender:male | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016076 | Recovery:no recovery | Gender:male | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016077 | Recovery:no recovery | Gender:male | Treatment:Kanamycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016003 | Recovery:no recovery | Gender:male | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016004 | Recovery:no recovery | Gender:male | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016005 | Recovery:no recovery | Gender:male | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016070 | Recovery:no recovery | Gender:male | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016071 | Recovery:no recovery | Gender:male | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00016072 | Recovery:no recovery | Gender:male | Treatment:Metronidazole treated | ug/100mg sample weight |
ESI negative ion mode | S00015997 | Recovery:no recovery | Gender:male | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00015998 | Recovery:no recovery | Gender:male | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00015999 | Recovery:no recovery | Gender:male | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016064 | Recovery:no recovery | Gender:male | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016065 | Recovery:no recovery | Gender:male | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00016066 | Recovery:no recovery | Gender:male | Treatment:Vancomycin treated | ug/100mg sample weight |
ESI negative ion mode | S00015956 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015957 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015958 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015959 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016025 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016026 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016027 | Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015960 | Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015961 | Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016028 | Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016029 | Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016030 | Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015982 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015983 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016049 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016050 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015991 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015992 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015993 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016058 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016059 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016060 | Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015984 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015985 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016051 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015994 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015995 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015996 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016061 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016062 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00016063 | Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin | ug/100mg sample weight |
ESI negative ion mode | S00015968 | Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015969 | Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015970 | Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016037 | Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016038 | Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015971 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015972 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015973 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016039 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016040 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016041 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016042 | Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015962 | Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015963 | Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015964 | Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016031 | Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016032 | Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016033 | Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015965 | Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015966 | Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00015967 | Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016034 | Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016035 | Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |
ESI negative ion mode | S00016036 | Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated | ug/100mg sample weight |